Bill Snyder Archive — Page 6 of 119

The team studying how to control sepsis in the lungs and kidneys includes, from left, Huan Qiao, MD, PhD Jacek Hawiger, MD, PhD, Jozef Zienkiewicz, PhD, and Yan Liu, MD, MS. (photo by Erin O. Smith)
October 22, 2025

New sepsis therapy developed at VUMC edges closer to the clinic

Jacek Hawiger and his colleagues report that a “peptide genomic therapy” given in combination with an antibiotic nearly doubles survival rates from sepsis in an animal model, compared to treatment with antibiotic alone.

October 22, 2025

Behind the curtain: Secrets of the volatile, delusional brain 

The VUMC approach, based on the “Feeling Safe Program” developed by British psychologist Daniel Freeman, targets specific factors that contribute to persecutory delusions, including worry, safety behaviors, avoidance and hallucinations (such as hearing voices).

October 20, 2025

Three VUMC leaders elected to the National Academy of Medicine

With more than 2,400 members, the NAM (formerly the Institute of Medicine) collaborates closely with its peer academies, the National Academy of Sciences and National Academy of Engineering, to provide independent and authoritative advice on matters of science, technology and health nationally and globally.

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
October 8, 2025

Vanderbilt leaders in filling the biomedical research pipeline shine at national meeting 

Vanderbilt has been training physician-scientists for more than 60 years. Many graduates have gone on to leadership positions in academia, government, industry and clinical practice.  

Katherine Van Schaik, MD, PhD, MA, positions skeletal remains in a CT scanner.
October 6, 2025

Study of old bones could lead to blood test for osteoporosis

Vanderbilt researchers are developing artificial intelligence they hope will speed the diagnosis and improve the treatment of osteoporosis.

Dan Roden, MD, chats with colleagues during a break in the symposium. (photo by Erin O. Smith)
October 1, 2025

Symposium honors personalized medicine leader Dan Roden

Roden is internationally known for his contributions to understanding arrhythmias and to the field of pharmacogenomics.